Cargando…

Longitudinal Dynamics of Circulating Tumor Cells and Circulating Tumor DNA for Treatment Monitoring in Metastatic Breast Cancer

Liquid biopsy–based biomarkers, including circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA), are increasingly important for the characterization of metastatic breast cancer (MBC). The aim of the study was to explore CTCs and ctDNA dynamics to better understand their potentially comple...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gerratana, Lorenzo, Davis, Andrew A., Zhang, Qiang, Basile, Debora, Rossi, Giovanna, Strickland, Kimberly, Franzoni, Alessandra, Allegri, Lorenzo, Mu, Zhaomei, Zhang, Youbin, Flaum, Lisa E., Damante, Giuseppe, Gradishar, William John, Platanias, Leonidas C., Behdad, Amir, Yang, Hushan, Puglisi, Fabio, Cristofanilli, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2021
Materias:	ORIGINAL REPORTS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202557/ https://www.ncbi.nlm.nih.gov/pubmed/34136741 http://dx.doi.org/10.1200/PO.20.00345

Ejemplares similares

Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer
por: Davis, Andrew A., et al.
Publicado: (2019)

Landscape of circulating tumour DNA in metastatic breast cancer
por: Davis, Andrew A., et al.
Publicado: (2020)

Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer
por: Mu, Zhaomei, et al.
Publicado: (2016)

Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancers
por: Shah, Ami N., et al.
Publicado: (2022)

Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis
por: Gerratana, Lorenzo, et al.
Publicado: (2023)

Circulating Tumor Cell Clusters Are Frequently Detected in Women with Early-Stage Breast Cancer
por: Reduzzi, Carolina, et al.
Publicado: (2021)

Dynamic Glycoprotein Hyposialylation Promotes Chemotherapy Evasion and Metastatic Seeding of Quiescent Circulating Tumor Cell Clusters in Breast Cancer
por: Dashzeveg, Nurmaa K., et al.
Publicado: (2023)

Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer
por: Gerratana, Lorenzo, et al.
Publicado: (2020)

Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancer
por: Davis, Andrew A., et al.
Publicado: (2022)

Concordance between genomic alterations assessed by next-generation sequencing in tumor tissue or circulating cell-free DNA
por: Chae, Young Kwang, et al.
Publicado: (2016)

Circulating tumor cells and novel biomarkers for prognostic and biological of breast cancer
por: Cristofanilli, M
Publicado: (2005)

In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis
por: Bulfoni, Michela, et al.
Publicado: (2016)

Image Analysis of Circulating Tumor Cells and Leukocytes Predicts Survival and Metastatic Pattern in Breast Cancer Patients
por: Da Col, Giacomo, et al.
Publicado: (2022)

Circulating tumor cells in breast cancer: A tool whose time has come of age
por: Swaby, Ramona F, et al.
Publicado: (2011)

Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells
por: Terai, Mizue, et al.
Publicado: (2015)

Genomic Aberrations in Circulating Tumor DNAs from Palbociclib-Treated Metastatic Breast Cancer Patients Reveal a Novel Resistance Mechanism
por: Abu-Khalaf, Maysa, et al.
Publicado: (2022)

Detection of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer()
por: Zheng, Xiumei, et al.
Publicado: (2017)

Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation
por: Gerratana, Lorenzo, et al.
Publicado: (2022)

Liquid Biopsy, an Everchanging Balance between Clinical Utility and Emerging Technologies
por: Cucciniello, Linda, et al.
Publicado: (2022)

Mitosis in circulating tumor cells stratifies highly aggressive breast carcinomas
por: Adams, Daniel L., et al.
Publicado: (2016)

Cell-free DNA comparative analysis of the genomic landscape of first-line hormone receptor-positive metastatic breast cancer from the US and China
por: Liu, Xiaoran, et al.
Publicado: (2021)

Circulating Tumor Cells for Glioma
por: Zhang, Huikai, et al.
Publicado: (2021)

APE1 and NPM1 protect cancer cells from platinum compounds cytotoxicity and their expression pattern has a prognostic value in TNBC
por: Malfatti, Matilde Clarissa, et al.
Publicado: (2019)

Single-Cells Isolation and Molecular Analysis: Focus on HER2-Low CTCs in Metastatic Breast Cancer
por: D’Amico, Paolo, et al.
Publicado: (2021)

CIRCULATING TUMOR CELLS
por: Paiva, Bruno
Publicado: (2022)

Circulating tumor cells in newly diagnosed inflammatory breast cancer
por: Mego, Michal, et al.
Publicado: (2015)

Application of circulating tumor cells scope technique on circulating tumor cell research
por: Yang, Dawei, et al.
Publicado: (2014)

Circulating Tumor Cell and Cell-free Circulating Tumor DNA in Lung Cancer
por: Nurwidya, Fariz, et al.
Publicado: (2016)

Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
por: Ye, Qianwei, et al.
Publicado: (2019)

Clinical Application of Circulating Tumor Cells and Circulating Tumor DNA in Uveal Melanoma
por: Beasley, Aaron, et al.
Publicado: (2018)

Circulating tumor cells and circulating tumor DNA in breast cancer diagnosis and monitoring
por: ALEMZADEH, EFFAT, et al.
Publicado: (2023)

Tumor Hypoxia and Circulating Tumor Cells
por: Tinganelli, Walter, et al.
Publicado: (2020)

Clinical and biological significance of circulating tumor cells, circulating tumor DNA, and exosomes as biomarkers in colorectal cancer
por: Jia, Shiyu, et al.
Publicado: (2017)

Detection of circulating tumor cells in patients with pituitary tumors
por: Hua, Gao, et al.
Publicado: (2018)

Association between circulating tumor cells and peripheral blood monocytes in metastatic breast cancer
por: De Giorgi, Ugo, et al.
Publicado: (2019)

Clinical application of liquid biopsy based on circulating tumor DNA in non-small cell lung cancer
por: Xin, Liu, et al.
Publicado: (2023)

Circulating Tumor Cells and Circulating Tumor DNA Provide New Insights into Pancreatic Cancer
por: Gao, Yang, et al.
Publicado: (2016)

Role of circulating tumor DNA and circulating tumor cells in breast cancer: History and updates
por: Chedid, Julien, et al.
Publicado: (2022)

Applications of Circulating Tumor Cells and Circulating Tumor DNA in Precision Oncology for Breast Cancers
por: Addanki, Sridevi, et al.
Publicado: (2022)

Detection of circulating tumor cells and evaluation of epithelial-mesenchymal transition patterns of circulating tumor cells in ovarian cancer
por: Jie, Xiao-Xiang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4cb8t5gvtk86ki77as05i9n2o2